Standard Diagnostics Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Corporate

  • Latest Deal Amount
  • $43.5M

Standard Diagnostics General Information

Description

Manufacturer and distributor of diagnostics reagents. The company manufactures diagnostics healthcare equipment includes rapid test kits, urine analyzing systems, enzyme-linked immunosorbent assay (ELISA) kits and medicine materials.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 46, Hagal-ro 15beon-gil, Giheung-gu, Yongin-si
  • Yongin-si, Gyeonggi-do 446-904
  • South Korea
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Acquirer
Corporate Office
  • 46, Hagal-ro 15beon-gil, Giheung-gu, Yongin-si
  • Yongin-si, Gyeonggi-do 446-904
  • South Korea

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Standard Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Corporate 30-Jun-2010 $43.5M Completed Generating Revenue
3. Merger/Acquisition 08-Feb-2010 Completed Generating Revenue
2. IPO 23-Jan-2003 $2M Completed Generating Revenue
1. Early Stage VC 01-Feb-2000 $2M $2M Completed Startup
To view Standard Diagnostics’s complete valuation and funding history, request access »

Standard Diagnostics Patents

Standard Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20100266606-A1 Antibody therapy for highly pathogenic avian influenza virus Inactive 26-Oct-2007
JP-4216838-B2 Non-continuous immunoassay device and immunoassay method using the same Inactive 02-Feb-2005
JP-2006215017-A Device for discontinuous immunoassay and method of immunoassay utilizing it Active 02-Feb-2005
EP-1844331-A1 Non-continuous immunoassay device and immunoassay method using the same Inactive 02-Feb-2005
EP-1844331-A4 Non-continuous immunoassay device and immunoassay method using the same Inactive 02-Feb-2005 A01K93/00
To view Standard Diagnostics’s complete patent history, request access »

Standard Diagnostics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Atinum Investment Venture Capital Minority
Hanrim Venture Capital Minority
Woori Venture Partners US Venture Capital Minority
To view Standard Diagnostics’s complete investors history, request access »

Standard Diagnostics FAQs

  • When was Standard Diagnostics founded?

    Standard Diagnostics was founded in 1999.

  • Where is Standard Diagnostics headquartered?

    Standard Diagnostics is headquartered in Yongin-si, South Korea.

  • What industry is Standard Diagnostics in?

    Standard Diagnostics’s primary industry is Diagnostic Equipment.

  • Is Standard Diagnostics a private or public company?

    Standard Diagnostics is a Private company.

  • What is the current valuation of Standard Diagnostics?

    The current valuation of Standard Diagnostics is .

  • What is Standard Diagnostics’s current revenue?

    The current revenue for Standard Diagnostics is .

  • How much funding has Standard Diagnostics raised over time?

    Standard Diagnostics has raised $43.5M.

  • Who are Standard Diagnostics’s investors?

    Atinum Investment, Hanrim, and Woori Venture Partners US have invested in Standard Diagnostics.

  • When was Standard Diagnostics acquired?

    Standard Diagnostics was acquired on 30-Jun-2010.

  • Who acquired Standard Diagnostics?

    Standard Diagnostics was acquired by Alere.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »